HLA-C and cancer: Moreover, immune components including the cells, co-stimulators, and MHC molecules were extremely low in the clusters enriching tumor-rejected features (Figure 8E), suggesting the essentiality of fully considering the negative effect on the antitumor immunity and the potential roles of the malignant cells and myeloid subsets in the process of cancer immunology (60–62).